Investigating the antiviral effects of Timosaponin BII on enterovirus A/B via network pharmacology and experimental validation

Key Points

• Antiviral effects were demonstrated through a combination of network pharmacology and experimental validation, targeting enterovirus A/B.
• Experimental validation revealed that timosaponin BII significantly inhibits viral replication, with a focus on key metrics related to viral loads.
• The approach included a detailed network pharmacology analysis to identify molecular targets of timosaponin BII against enteroviruses.
• These findings highlight the therapeutic potential of timosaponin BII, warranting further investigation in clinical settings.